tert-Butyl (4-formylpyridin-3-yl)carbamate

Catalog No.: 
ACXWMD293
CAS No.: 
116026-95-0
Molecular Formula: 
C11H14N2O3
Molecular Weight: 
222.24
tert-Butyl (4-formylpyridin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$198.00In stockIn stock
25g97%$792.00In stockIn stock
100g97%$2612.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (4-formylpyridin-3-yl)carbamate
IUPAC Nametert-butyl (4-formylpyridin-3-yl)carbamate
MDL No.MFCD02683209
Molecular FormulaC11H14N2O3
Molecular Weight222.24
SMILESO=C(OC(C)(C)C)NC1=C(C=O)C=CN=C1
InChI KeyYLKONQAWPOHLPX-UHFFFAOYSA-N
Synonym(4-FORMYL-PYRIDIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER | tert-Butyl (4-formylpyridin-3-yl)carbamate
CAS No.116026-95-0
PubChem CID14177126

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXWMD293 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDXEQ134 route compound structure diagram
    ACDXEQ13456700-70-0In Stock
  2. Then
  3. ACXWMD293 route product structure diagram
    ACXWMD293116026-95-0In Stock
Inquiry

2. ACXWMD293 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVQMA160 route compound structure diagram
    ACVQMA160885275-14-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXWMD293 route product structure diagram
    ACXWMD293116026-95-0In Stock
Inquiry

3. ACXWMD293 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDXEQ134 route compound structure diagram
    ACDXEQ13456700-70-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXWMD293 route product structure diagram
    ACXWMD293116026-95-0In Stock
Inquiry

Comments (0)